On January 24, 2022 Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported that Douglas E. Onsi, President and Chief Executive Officer, and Cynthia Sirard, MD, Chief Medical Officer, will present a corporate overview at the B. Riley Securities Oncology Investor Conference (Press release, Leap Therapeutics, JAN 24, 2022, View Sourcenews-releases/news-release-details/leap-therapeutics-present-b-riley-securities-oncology-investor" target="_blank" title="View Sourcenews-releases/news-release-details/leap-therapeutics-present-b-riley-securities-oncology-investor" rel="nofollow">View Source [SID1234606733]). The conference will be held in a virtual meeting format.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Leap Presentation Details:

B. Riley Securities Oncology Investor Conference
Date: Thursday, January 27, 2022
Time: 10:00 a.m. Eastern Time

The presentation will be webcast live and may be accessed on the Investors page of the company’s website at View Source, where a replay of the event will also be available for a limited time.